2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide

C28H27BrN4O4 — CID 158012684

IUPAC2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide
SMILESCCc1cccc(NC(=O)CC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(Br)CO)C2=O)c1
InChIInChI=1S/C28H27BrN4O4/c1-2-18-8-7-9-19(14-18)31-26(36)15-23-28(37)33(16-25(35)21(29)17-34)24-12-4-3-10-20(24)27(32-23)22-11-5-6-13-30-22/h3-14,21,23,34H,2,15-17H2,1H3,(H,31,36)
InChIKeyXXJICFRBFMJAHX-UHFFFAOYSA-N
MW563.45 g/mol
LogP3.55
Rot. Bonds9

About 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide

2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide (PubChem CID 158012684) has the molecular formula C28H27BrN4O4 and a molecular weight of 563.45 g/mol. Its IUPAC name is 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide.

Molecular Properties

Compound Name2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide
PubChem CID158012684
Molecular FormulaC28H27BrN4O4
Molecular Weight563.45 g/mol
Exact Mass562.12
IUPAC Name2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide
SMILESCCc1cccc(NC(=O)CC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(Br)CO)C2=O)c1
InChIInChI=1S/C28H27BrN4O4/c1-2-18-8-7-9-19(14-18)31-26(36)15-23-28(37)33(16-25(35)21(29)17-34)24-12-4-3-10-20(24)27(32-23)22-11-5-6-13-30-22/h3-14,21,23,34H,2,15-17H2,1H3,(H,31,36)
InChIKeyXXJICFRBFMJAHX-UHFFFAOYSA-N
XLogP3.55
TPSA111.96 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500563.45
LogP ≤ 53.55
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide?
The IUPAC name of 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide (CID 158012684) is 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide.
What is the SMILES notation for 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide?
The canonical SMILES for 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide is CCc1cccc(NC(=O)CC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(Br)CO)C2=O)c1.
What is the InChIKey of 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide?
The InChIKey is XXJICFRBFMJAHX-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H27BrN4O4/c1-2-18-8-7-9-19(14-18)31-26(36)15-23-28(37)33(16-25(35)21(29)17-34)24-12-4-3-10-20(24)27(32-23)22-11-5-6-13-30-22/h3-14,21,23,34H,2,15-17H2,1H3,(H,31,36).
What are the key properties of 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide?
2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide has a molecular weight of 563.45 g/mol, XLogP of 3.55, 9 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-(3-bromo-4-hydroxy-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-N-(3-ethylphenyl)acetamide is sourced from PubChem (CID 158012684), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).